Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Globus Medical

GMED
Current price
74.88 USD +1.27 USD (+1.73%)
Last closed 73.54 USD
ISIN US3795772082
Sector Healthcare
Industry Medical Devices
Exchange NYSE
Capitalization 10 005 192 704 USD
Yield for 12 month +59.35 %
1Y
3Y
5Y
10Y
15Y
GMED
21.11.2021 - 28.11.2021

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania. Address: 2560 General Armistead Avenue, Audubon, PA, United States, 19403

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

79.54 USD

P/E ratio

365.85

Dividend Yield

Current Year

+1 568 476 000 USD

Last Year

+1 022 843 000 USD

Current Quarter

+629 691 000 USD

Last Quarter

+606 666 000 USD

Current Year

+1 020 302 000 USD

Last Year

+759 118 000 USD

Current Quarter

+339 942 000 USD

Last Quarter

+335 503 000 USD

Key Figures GMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 579 852 032 USD
Operating Margin TTM 18.72 %
PE Ratio 365.85
Return On Assets TTM 6.11 %
PEG Ratio 1.9709
Return On Equity TTM 1.37 %
Wall Street Target Price 79.54 USD
Revenue TTM 2 236 529 920 USD
Book Value 29.38 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 115.9 %
Dividend Yield
Gross Profit TTM 759 118 000 USD
Earnings per share 0.2 USD
Diluted Eps TTM 0.2 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY -59.6 %
Profit Margin 1.82 %

Dividend Analytics GMED

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History GMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation GMED

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 365.85
Forward PE 21.692
Enterprise Value Revenue 4.4462
Price Sales TTM 4.4735
Enterprise Value EBITDA 25.1142
Price Book MRQ 2.4917

Financials GMED

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GMED

For 52 weeks

43.39 USD 75.98 USD
50 Day MA 71.07 USD
Shares Short Prior Month 3 531 284
200 Day MA 62.77 USD
Short Ratio 4.37
Shares Short 2 836 112
Short Percent 2.81 %